Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection (Q36322131)

13 August 2017

1 reference

title

Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection (English)

1 reference

13 August 2017

Marina S Boukhvalova

1 reference

13 August 2017

Jorge C G Blanco

1 reference

13 August 2017

Gregory A Prince

1 reference

13 August 2017

Patrick Hemming

1 reference

13 August 2017

Martin G Ottolini

series ordinal

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Expert Review of Anti-infective Therapy

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

945-955

1 reference

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

An outbreak of respiratory syncytial virus in a bone marrow transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

State of the art: bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Animal models of respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Immune responses and disease enhancement during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Immunological determinants of disease caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Antigenic analysis of a putative new strain of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

The future of respiratory syncytial virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Immunoprophylaxis of respiratory syncytial virus: global experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

COX-2 expression in asthmatic airways: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Prostaglandins and the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Molecular pathology of allergic disease. II: Upper airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Release of prostaglandin D2 into human airways during acute antigen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Role of prostanoid DP receptor variants in susceptibility to asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

A new view of prostaglandin E regulation of the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Cellular signalling in programmed cell death (apoptosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

The lung as a privileged site for the beneficial actions of PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

The role and regulation of COX-2 during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Increases in plasma concentrations of a prostaglandin metabolite in acute airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus bronchiolitis: A double-blind dexamethasone efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Comparison of corticosteroids for treatment of respiratory syncytial virus bronchiolitis and pneumonia in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Respiratory syncytial virus infection in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.945

21 January 2018

Identifiers

DOI

10.1586/14787210.3.6.945

1 reference

13 August 2017

1 reference